ZA200707420B - Methods and reagents for treatment and diagnosis of age-related macular degeneration - Google Patents
Methods and reagents for treatment and diagnosis of age-related macular degenerationInfo
- Publication number
- ZA200707420B ZA200707420B ZA200707420A ZA200707420A ZA200707420B ZA 200707420 B ZA200707420 B ZA 200707420B ZA 200707420 A ZA200707420 A ZA 200707420A ZA 200707420 A ZA200707420 A ZA 200707420A ZA 200707420 B ZA200707420 B ZA 200707420B
- Authority
- ZA
- South Africa
- Prior art keywords
- reagents
- diagnosis
- age
- treatment
- methods
- Prior art date
Links
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US65307805P | 2005-02-14 | 2005-02-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200707420B true ZA200707420B (en) | 2009-04-29 |
Family
ID=39307957
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200707420A ZA200707420B (en) | 2005-02-14 | 2006-02-14 | Methods and reagents for treatment and diagnosis of age-related macular degeneration |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN101160412A (en) |
ZA (1) | ZA200707420B (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TR201802933T4 (en) * | 2010-03-30 | 2018-03-21 | Childrens Hospital & Res Center At Oakland | The modified factor h binding proteins (fhbp) and their method of use. |
CN102978204B (en) * | 2011-11-11 | 2018-06-08 | 张康 | The assay kit and assay method of CFHR1 and oxidation phosphocholine in CFHR1 genotype, high-density lipoprotein |
AU2015218903B2 (en) * | 2014-02-20 | 2020-10-15 | Allergan, Inc. | Complement component C5 antibodies |
KR20230149865A (en) * | 2014-02-26 | 2023-10-27 | 알러간, 인코포레이티드 | Complement component c5 antibodies |
PT3472149T (en) * | 2016-06-21 | 2023-11-23 | Orion Opthalmology Llc | Heterocyclic prolinamide derivatives |
EP3791180A1 (en) * | 2018-05-10 | 2021-03-17 | The University Of Manchester | Methods for assessing macular degeneration |
AU2020371663A1 (en) * | 2019-10-22 | 2022-05-19 | Applied Genetic Technologies Corporation | Adeno-associated virus (AAV)vectors for the treatment of age-related macular degeneration and other ocular diseases and disorders |
-
2006
- 2006-02-14 ZA ZA200707420A patent/ZA200707420B/en unknown
- 2006-02-14 CN CNA2006800124949A patent/CN101160412A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CN101160412A (en) | 2008-04-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201005922B (en) | Method of treatment of age-related macular degeneration (amd) | |
IL196016A0 (en) | Diagnosis and treatment of age related macular degeneration | |
ZA200710371B (en) | Compositions and methods for treating hyperproliferative epidermal diseases | |
PL2508182T3 (en) | Hydralazine for use in the treatment of age-related macular degeneration | |
GB2421433B (en) | Use of compositions for treating age related macular degeneration or dystrophy | |
IL233634A0 (en) | Methods, compositions, and kits for the treatment of medical conditions | |
EP2089016A4 (en) | Method for treatment of macular degeneration | |
EP1855729A4 (en) | Method of sterilization | |
IL187553A0 (en) | Methods of treating cancer and other conditions or disease states using lfmau and ldt | |
ZA200707420B (en) | Methods and reagents for treatment and diagnosis of age-related macular degeneration | |
EP1937197A4 (en) | Method and device for the macular degeneration treatment | |
HK1171972A1 (en) | Methods and products for treatment of diseases | |
EP1858499A4 (en) | Methods for treatment of retinal degenerative disease | |
IL188728A0 (en) | Methods of treating epileptogenesis | |
IL173971A0 (en) | Compositions and methods for treating and preventing age-related macular degeneration | |
EP2046366A4 (en) | Method of treatment of age-related macular degeneration | |
EP1866647A4 (en) | A method of diagnosis and treatment and agents useful for same | |
EP2252895A4 (en) | Methods and compositions for diagnosis of age-related macular degeneration | |
ZA200808363B (en) | Compounds and methods for diagnosis and treatment of leishmaniasis | |
EP2083841A4 (en) | Treatment for age-related macular degeneration and other diseases of the eye | |
GB0625844D0 (en) | The treatment of macular degeneration | |
GB2442881B (en) | Methods for altering gene expression and methods of treatment utilizing same | |
EP1962882A4 (en) | Compositions and methods for treatment of diabetes | |
IL196173A0 (en) | Use of agents that act on t cells for treatment of age-related macular degeneration | |
GB0512568D0 (en) | Method of diagnosis and treatment |